Aripiprazole    (DrugBank: Aripiprazole)

2 diseases
IDDisease name (Link within this page)Number of trials
6Parkinson disease1
206Fragile X syndrome1

6. Parkinson disease    [ 2,123 clinical trials,   2,046 drugs,   (DrugBank: 324 drugs),   183 drug target genes,   198 drug target pathways]
Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,123 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00095810
(ClinicalTrials.gov)
July 20039/11/2004Aripiprazole in Patients With Psychosis Associated With Parkinson's DiseaseAn Open-Label Study of Aripiprazole to Evaluate the Safety and Tolerability in Patients With Psychosis Associated With Parkinson's DiseaseParkinson's Disease;PsychosesDrug: aripiprazoleOtsuka Pharmaceutical Development & Commercialization, Inc.Otsuka America PharmaceuticalCompleted50 YearsN/ABoth50Phase 4United States

206. Fragile X syndrome    [ 98 clinical trials,   73 drugs,   (DrugBank: 27 drugs),   46 drug target genes,   57 drug target pathways]
Searched query = "Fragile X syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 98 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00420459
(ClinicalTrials.gov)
April 20079/1/2007A Prospective Open-label Study of Aripiprazole in Fragile X SyndromeAripiprazole in Fragile X SyndromeFragile X SyndromeDrug: AripiprazoleIndiana University School of MedicineNULLCompleted5 Years35 YearsAll12Phase 2United States